Endothelial and platelet microparticles (EMPs, CD31+/CD42a−; PMPs, CD31+/CD42a+) have been used as surrogate markers of endothelial dysfunction and cardiovascular diseases [15,16,17,18,19,20]. This evidence concerns the gene PECAM1 and endothelial dysfunction.